149 related articles for article (PubMed ID: 29882112)
1. Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome.
Shimamura Y; Maeda T; Takizawa H
Clin Exp Nephrol; 2019 Jan; 23(1):142-143. PubMed ID: 29882112
[No Abstract] [Full Text] [Related]
2. Bevacizumab-associated glomerular microangiopathy.
Person F; Rinschen MM; Brix SR; Wulf S; Noriega MLM; Fehrle W; Schmitz J; Schwarz A; Ivanyi P; Steinmetz OM; Reinhard L; Hoxha E; Zipfel PF; Bräsen JH; Wiech T
Mod Pathol; 2019 May; 32(5):684-700. PubMed ID: 30552416
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
Morimoto M; Arai T; Matsuura M; Ono Y
CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.
Hilburg R; Geara AS; Qiu MK; Palmer MB; Chiang EY; Burger RA; Hogan JJ
Clin Nephrol; 2021 Jul; 96(1):51-59. PubMed ID: 33896447
[TBL] [Abstract][Full Text] [Related]
5. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
6. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
7. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
[TBL] [Abstract][Full Text] [Related]
8. A severe case of bevacizumab-induced thrombotic microangiopathy.
Bektas M; Samancı NS; Cokgezer S; Keskin D; Demirelli FH
J Oncol Pharm Pract; 2019 Oct; 25(7):1754-1757. PubMed ID: 30253727
[TBL] [Abstract][Full Text] [Related]
9. [Interferon ß, nephrotic syndrome and thrombotic microangiopathy].
Quintana LF; Campistol JM
Med Clin (Barc); 2015 Jan; 144(2):65-6. PubMed ID: 25458512
[No Abstract] [Full Text] [Related]
10. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
Katagiri D; Hinoshita F
CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
[TBL] [Abstract][Full Text] [Related]
11. Nephrotic syndrome as a manifestation of thrombotic microangiopathy due to long-term use of sunitinib.
Nieto-Ríos JF; García-Prada CA; Aristizabal-Alzate A; Zuluaga-Valencia G; Cadavid-Aljure D; Serna-Higuita LM; Arias LF
Nefrologia (Engl Ed); 2022; 42(6):722-726. PubMed ID: 36925325
[TBL] [Abstract][Full Text] [Related]
12. Renal thrombotic microangiopathy caused by bevacizumab.
Horino T; Ichii O; Shimamura Y; Terada Y
Nephrology (Carlton); 2018 Apr; 23(4):378-379. PubMed ID: 29520904
[No Abstract] [Full Text] [Related]
13. Bevacizumab-induced immunoglobulin A vasculitis with nephritis: A case report.
Endo Y; Negishi K; Hirayama K; Suzuki H; Shimizu A
Medicine (Baltimore); 2019 Nov; 98(45):e17870. PubMed ID: 31702653
[TBL] [Abstract][Full Text] [Related]
14. The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Usui J; Yokoyama C; Hagiwara M; Hirayasu K; Kojima T; Yoshino T; Nishiyama H; Hara M; Yamagata K
Clin Lab; 2016 Dec; 62(12):2413-2417. PubMed ID: 28164557
[TBL] [Abstract][Full Text] [Related]
15. A case of bevacizumab-induced non-remitting thrombotic microangiopathy.
Wong YHS; Sinniah R; Rosman J
Intern Med J; 2020 Nov; 50(11):1432-1434. PubMed ID: 33215823
[No Abstract] [Full Text] [Related]
16. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
[TBL] [Abstract][Full Text] [Related]
17. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
[TBL] [Abstract][Full Text] [Related]
18. [Nephrotic syndrome and acute kidney injury associated with celiac disease: report of one case].
Vega J; Díaz R; Méndez GR; Goecke H
Rev Med Chil; 2013 Mar; 141(3):381-7. PubMed ID: 23900331
[TBL] [Abstract][Full Text] [Related]
19. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.
Liou AA; Skiver BM; Yates E; Persad P; Meyer D; Farland AM; Rocco MV
Am J Kidney Dis; 2019 May; 73(5):615-619. PubMed ID: 30528935
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy secondary to steroid pulse therapy administered for refractory nephrotic syndrome.
Miyamoto T; Ishikawa Y; Yamamoto J; Yamamura T; Kawata T
Intern Med; 2013; 52(18):2099-103. PubMed ID: 24042520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
